Chevy Chase Trust Holdings, Inc. Moderna, Inc. Transaction History

Chevy Chase Trust Holdings, Inc.

$35.7 Billion
Q3 2025

A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 176,725 shares of MRNA stock, worth $4.38 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

176,725

Previous 179,768 1.69%

Holding current value

$4.38 Million

Previous $4.96 Million 7.97%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$23.51 - $34.67 $71,540 - $105,500	-3,043 Reduced 1.69%	176,725 $4.56 Million
Q2 2025 Jul 29, 2025	BUY	$23.65 - $28.54 $51,107 - $61,674	2,161 Added 1.22%	179,768 $4.96 Million
Q1 2025 Apr 23, 2025	SELL	$28.35 - $47.53 $2,721 - $4,562	-96 Reduced 0.05%	177,607 $5.04 Million
Q4 2024 Jan 30, 2025	SELL	$36.85 - $63.93 $144,194 - $250,158	-3,913 Reduced 2.15%	177,703 $7.39 Million
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $65,421 - $128,643	-1,028 Reduced 0.56%	181,616 $12.1 Million

Q2 2024 Jul 22, 2024	SELL	$101.21 - $166.61 $166,692 - $274,406	-1,647 Reduced 0.89%	182,644 $21.7 Million
Q1 2024 May 03, 2024	SELL	$85.37 - $115.44 $115,932 - $156,767	-1,358 Reduced 0.73%	184,291 $19.6 Million
Q4 2023 Jan 24, 2024	SELL	$69.51 - $104.43 $57,206 - $85,945	-823 Reduced 0.44%	185,649 $18.5 Million
Q3 2023 Oct 23, 2023	SELL	$96.41 - $126.61 $238,903 - $313,739	-2,478 Reduced 1.31%	186,472 $19.3 Million
Q2 2023 Jul 25, 2023	SELL	$118.5 - $160.53 $402,781 - $545,641	-3,399 Reduced 1.77%	188,950 $23 Million
Q1 2023 May 17, 2023	BUY	$135.66 - $197.02 $25.3 Million - $36.7 Million	186,441 Added 3155.74%	192,349 $29.5 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $25 Million - $36.3 Million	-184,483 Reduced 96.9%	5,908 $907 Million
Q4 2022 Feb 09, 2023	SELL	$118.38 - $210.04 $1.79 Million - $3.18 Million	-15,138 Reduced 7.37%	190,391 $34.2 Million
Q3 2022 Nov 04, 2022	SELL	$118.07 - $194.18 $407,695 - $670,503	-3,453 Reduced 1.65%	205,529 $24.3 Million
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $465,240 - $701,415	-3,972 Reduced 1.87%	208,982 $29.9 Million
Q1 2022 Apr 27, 2022	BUY	$126.46 - $235.05 $76,761 - $142,675	607 Added 0.29%	212,954 $36.7 Million
Q4 2021 Jan 31, 2022	SELL	$225.82 - $368.51 $939,185 - $1.53 Million	-4,159 Reduced 1.92%	212,347 $53.9 Million
Q3 2021 Oct 20, 2021	BUY	$221.9 - $484.47 $48 Million - $105 Million	216,506 New	216,506 $83.3 Million

Others Institutions Holding MRNA

# of Institutions

846

Shares Held

258M

Call Options Held

40.2M

Put Options Held

44M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $9.69B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.

Account

Chevy Chase Trust Holdings, Inc. Moderna, Inc. Transaction History